LEADER 01427nam  2200445   450 
001 9910819764403321
005 20200520144314.0
010   $a1-118-88994-0
010   $a1-118-88991-6
035   $a(CKB)24989753000041
035   $a(Au-PeEL)EBL1895710
035   $a(CaPaEBR)ebr11026086
035   $a(CaONFJC)MIL770050
035   $a(OCoLC)899267729
035   $a(MiAaPQ)EBC1895710
035   $a(EXLCZ)9924989753000041
100   $a20150310h20152015  uy             0
101 0 $aeng
135   $aur|||||||||||
181   $2rdacontent
182   $2rdamedia
183   $2rdacarrier
200 10$aCardiovascular diseases $efrom molecular pharmacology to evidence-based therapeutics /$fY. Robert Li
210  1$aHoboken, New Jersey :$cJohn Wiley & Sons Inc.,$d2015.
210  4$d2015
215   $a1 online resource (504 pages) $cillustrations (some color)
320   $aIncludes bibliographical references and index.
606   $aCardiovascular system$xDiseases$xChemotherapy
606   $aCardiovascular system$xDiseases$xDiagnosis
615  0$aCardiovascular system$xDiseases$xChemotherapy.
615  0$aCardiovascular system$xDiseases$xDiagnosis.
676   $a616.1/061
700   $aLi$b Robert Y.$01694850
801  0$bMiAaPQ
801  1$bMiAaPQ
801  2$bMiAaPQ
906   $aBOOK
912   $a9910819764403321
996   $aCardiovascular diseases$94073672
997   $aUNINA